# Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-hla-dqb1-hla-b-pharmacogenetic-guided-treatment-and-blood/

## Facts

| Field | Value |
| --- | --- |
| Author Names | François Girardin,Antoine Poncet,Arnaud Perrier,Nathalie Vernaz,Mark Pletscher,Caroline Samer,Jeffrey A. Lieberman,Jean Villard |
| Citations | 42 |
| DOI | 10.1038/s41397-017-0004-2 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41397-017-0004-2.pdf |
| OpenAlex ID | https://openalex.org/W2781558796 |
| PMID | 29298994 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Mark Pletscher](https://scholariq.org/researchers/mark-pletscher/)

## Paper primary topic

- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)

## Paper topics

- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.